Idaho will receive about $85,000 from two separate Medicaid fraud settlements with prescription drug manufacturers.
State Attorney General Lawrence Wasden said Tuesday that a settlement with KV Pharmaceutical will net the state $64,500, and a separate resolution with Dava Pharmaceuticals Inc. will pay Idaho $20,000.
KV Pharmaceutical resolves allegations that a subsidiary company failed to report to the federal government that two of its products didn’t qualify for Medicaid coverage, submitting false quarterly reports in the process.
Idaho joins several other states in settling allegations that Dava Pharmaceuticals Inc. underpaid the Medicaid Prescription Drug Rebate Program from 2005 to 2009.
Dava is accused of misrepresenting drugs as generic instead of branded to lower its legally required Medicaid rebate payments.
Idaho Medicaid will receive $76,000 of the settlement funds.
Topics Fraud
Was this article valuable?
Here are more articles you may enjoy.
US Dog-Related Injury Claims Hit $1.12 Billion in 2023: Triple-I, State Farm Report 
Florida’s Slide Insurance Secures $210 Million Catastrophe Bond 
DeSantis Signs Bill Barring Local Worker Heat Protection Measures 
Harvard Study Again Stirs the Pot on Demotech Ratings of Florida Carriers 
